(Q47952949)

PubMed publication ID

23879272

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23879272%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Prevalence and prognostic value of conduction disturbances at the time of diagnosis of cardiac AL amyloidosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932035&resulttype=core&format=json

13 May 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932035&resulttype=core&format=json

13 May 2020

Giampaolo Merlini

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932035&resulttype=core&format=json

13 May 2020

Roberta Mussinelli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932035&resulttype=core&format=json

13 May 2020

Stefano Perlini

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932035&resulttype=core&format=json

13 May 2020

author name string

Michele Boldrini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932035&resulttype=core&format=json

13 May 2020

Francesco Salinaro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932035&resulttype=core&format=json

13 May 2020

Ambra Raimondi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932035&resulttype=core&format=json

13 May 2020

Alessio Alogna

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932035&resulttype=core&format=json

13 May 2020

Francesco Musca

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932035&resulttype=core&format=json

13 May 2020

publication date

20 January 2013

1 reference

PubMed publication ID

23879272

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23879272%20AND%20SRC:MED&resulttype=core&format=json

Annals of Noninvasive Electrocardiology

5 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932035&resulttype=core&format=json

13 May 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932035&resulttype=core&format=json

13 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932035&resulttype=core&format=json

13 May 2020

page(s)

327-335

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932035&resulttype=core&format=json

Molecular mechanisms of amyloidosis

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Diagnosis and management of the cardiac amyloidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Dangerous small B-cell clones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Prognostic value of fragmented QRS in cardiac AL amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

21 January 2018

Amyloid heart disease

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Importance of the echocardiographic evaluation of right ventricular function in patients with AL amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Right ventricular function in AL amyloidosis: characteristics and prognostic implication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Midwall mechanics are improved after regression of hypertensive left ventricular hypertrophy and normalization of chamber geometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Out-of-hospital cardiac arrest in patients with cardiac amyloidosis: presenting rhythms, management and outcomes in four patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Gross anatomy of the human cardiac conduction system with comparative morphological and developmental implications for human application

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Amyloidosis: pathogenesis and new therapeutic options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Clinically significant cardiac amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANEC.12032

Amyloid cardiomyopathy in systemic non-hereditary amyloidosis. Clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis

21 January 2018

1 reference

12 December 2020

A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis.

1 reference

12 December 2020

Symptomatic conduction system disease in cardiac amyloidosis

1 reference

12 December 2020

Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective.

1 reference

12 December 2020

Cardiac amyloidosis: a treatable disease, often overlooked

1 reference

12 December 2020

Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement

1 reference

12 December 2020

Recognition and significance of intraventricular block due to myocardial infarction (peri-infarction block)

1 reference

12 December 2020

Amyloidosis (AL). Clinical and laboratory features in 229 cases

1 reference

12 December 2020

Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension

1 reference

12 December 2020

Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients

1 reference

12 December 2020

Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities

1 reference

12 December 2020

Non-invasive predictors of survival in cardiac amyloidosis

1 reference

12 December 2020

The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement

1 reference

12 December 2020

ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Commit

1 reference

12 December 2020

Comparison of electrocardiographic findings in patients with AL (primary) amyloidosis and in familial amyloid polyneuropathy and anginal pain and their relation to histopathologic findings

1 reference

12 December 2020

Identifiers

DOI

10.1111/ANEC.12032

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932035&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6932035&resulttype=core&format=json

13 May 2020

PubMed publication ID

23879272

1 reference